Ryan White HIV/AIDS Program Part D - Women, Infants, Children and Youth (WICY) Grant Supplemental Funding | HRSA 25 050

Frequently Asked Questions (FAQs)

What is the Ryan White HIV/AIDS Program (RWHAP) Part D WICY Supplemental Funding opportunity (HRSA 25 050)?

This is a discretionary supplemental grant opportunity from the Health Resources and Services Administration (HRSA) under the Ryan White HIV/AIDS Program (RWHAP) Part D. It is intended to strengthen access to high quality, family-centered HIV health care services for low-income women, infants, children, and youth (WICY). The funding is supplemental, meaning it is designed to build on existing Part D-funded systems of care rather than create entirely new programs from scratch.

What is the main purpose of this supplemental funding?

The purpose is to help current RWHAP Part D WICY recipients make targeted improvements that can be carried out quickly and demonstrate near-term impact for WICY populations. HRSA frames this as a focused opportunity to improve access, quality, and/or coordination of HIV care delivered in a family-centered model.

Who is eligible to apply?

Eligibility is limited to current recipients in specific existing Part D service area programs. Only organizations that currently receive funding under HRSA-22-037 (RWHAP Part D WICY Existing Geographic Service Areas) or HRSA-22-156 (RWHAP Part D WICY Limited Existing Geographic Service Areas) may apply.

Is this an open competition for new applicants that do not currently receive Part D WICY funding?

No. This opportunity is not an open competition for new entrants. It is designed specifically for established Part D WICY recipients to carry out a targeted improvement using supplemental support.

What populations should benefit from the proposed activity?

The proposed activity should benefit low-income women, infants, children, and youth (WICY) served through Part D, and it should align with a family-centered HIV care approach.

What is meant by a "family-centered" model in this opportunity?

Based on the opportunity description, the activity should be designed to improve HIV health care services for WICY populations in a way that is organized around the needs of families (for example, improving how care is accessed, coordinated, and delivered for women and their children/youth). The notice emphasizes strengthening family-centered HIV care, but applicants should use the full funding notice for any additional HRSA definitions or expectations.

What is the expected scope of work for an application?

The scope is intentionally narrow and time-limited. Applicants are expected to propose one short-term activity rather than a broad, multi-component project. HRSA indicates that strong applications will propose an activity that is well-defined, realistic to complete within one year, and clearly tied to improving access, quality, or coordination of HIV care for WICY clients.

How long is the period of performance?

The proposed activity must be fully completed within a one-year period of performance.

Can an applicant propose multiple activities if they are related?

The description states applicants are expected to propose one short-term activity. That framing suggests proposals should remain focused on a single discrete activity that can be completed within one year.

What types of activities can be proposed under this funding?

Proposed work can fall under either (1) an HIV Care Innovation activity or (2) an Infrastructure Development activity. In general terms, innovation activities focus on service delivery improvements (changing how care is provided), while infrastructure activities focus on strengthening systems, processes, workforce, or tools that enable high-performing care.

What is the difference between an HIV Care Innovation activity and an Infrastructure Development activity?

As described in the opportunity summary: HIV Care Innovation generally refers to improvements in service delivery that change how care is provided. Infrastructure Development generally refers to strengthening the underlying systems and supports (processes, workforce, tools) that enable high-performing, coordinated care.

Is HRSA allowing applicants to build on previously funded work?

Yes. HRSA allows applicants to propose an expansion of an activity that was previously supported under certain prior funding streams, specifically: FY2023 or FY2024 RWHAP Part D Supplemental funding (HRSA-23-050 and HRSA-24-061) or Part C Capacity Development funding (HRSA-23-052 and HRSA-24-062).

Are applicants allowed to repeat the same activity that was funded in FY2023 or FY2024?

No. HRSA is explicit that it will not fund the same activity in FY2025 that it already funded for the applicant in FY2023 or FY2024. Applicants should avoid re-proposing an identical project and instead propose a true next step, scale-up, refinement, or new application of lessons learned.

What counts as an "expansion" rather than a repeat of a previously funded activity?

The application should make a clear and credible case that the FY2025 proposal builds on prior accomplishments rather than restating them. The summary indicates expansions may include: increasing reach (serving more WICY clients or additional subpopulations), deepening intensity (improving integration or follow-up), enhancing quality (standardizing workflows or strengthening clinical supports), or extending capability (adding a new component that was not funded before).

If building on prior funding, what should the rationale include?

HRSA expects applicants to explain what was accomplished previously, what gaps remain, and how the proposed FY2025 activity builds on earlier results to further the original objectives. The rationale should clearly show how the new work is a next step rather than a duplicate.

What kinds of outcomes is HRSA looking for from this supplemental funding?

The opportunity emphasizes near-term, measurable improvement in family-centered HIV care access, quality, and/or coordination for WICY populations, delivered through one discrete activity completed within one year.

How many awards does HRSA expect to make?

The funding notice details provided indicate an expected 25 awards.

What is the Assistance Listing (CFDA) number for this opportunity?

The opportunity is listed under Assistance Listing/CFDA 93.153.

What is the application deadline?

The application deadline is February 10, 2025.

When was this opportunity created?

The opportunity was created on December 10, 2024.

Is there an award ceiling (maximum award amount) listed?

The award ceiling is listed as 0 in the summary provided. This typically indicates the ceiling is not specified in the public summary and that applicants should rely on the full funding notice for budget constraints, guidance, or HRSA's allocation approach.

Does an award ceiling of 0 mean no funding limit?

Not necessarily. In this context, the summary notes that a ceiling listed as 0 typically means the ceiling is not specified in the public summary. Applicants should consult the full notice for any budget limitations or HRSA guidance.

What makes a strong proposal for this opportunity?

Based on the description, strong proposals are typically focused, well-defined, realistic to complete within one year, and clearly tied to improving access, quality, or coordination of HIV care for WICY clients in a family-centered model. If building on prior work, strong proposals also clearly demonstrate how the activity is an expansion rather than a repeat.

Can an applicant propose an activity that is entirely new (not connected to prior supplemental or capacity development funding)?

The summary emphasizes that HRSA allows expansions of previously supported activities under the specified prior funding streams. It does not state that an applicant must build on prior supplemental/capacity funding; however, eligibility is limited to current Part D recipients, and proposals are expected to be targeted, short-term, and quickly implementable. Applicants should use the full notice for definitive requirements.